After approval was obtained from the Washington University Human Research Protection Office (HRPO), cases of oropharyngeal squamous cell carcinoma treated from 1997–2007 were identified from ...
Activity of combined therapy with bevacizumab (BV) and paclitaxel (P) in HER2/neu negative patients with widely disseminated metastatic breast cancer (WDMBC). Background: Triple-negative breast ...
Previous studies have shown that immunohistochemistry improves the detection rate of Merkel cell carcinoma in lymph node biopsies. Indeed, Su et al 14 have reported a ~40% rate of immunohistochemistry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results